Beijing, China

Shouye Feng



 

Average Co-Inventor Count = 11.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Shouye Feng: Innovator in Pharmaceutical Compounds

Introduction

Shouye Feng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as kinase inhibitors. With a total of 4 patents to his name, Feng's work is paving the way for advancements in drug development.

Latest Patents

Feng's latest patents include innovative compounds and their preparation methods. One notable patent is for an oxazino-quinazoline and oxazino-quinoline type compound. This invention provides a preparation method and various uses, particularly in creating drugs that act as kinase inhibitors. Another significant patent involves urea-substituted aromatic ring-linked dioxinoquinoline compounds. This invention also includes a preparation method and highlights the compound's use as a drug for treating disorders related to tyrosine kinase.

Career Highlights

Shouye Feng is currently associated with Beijing Scitech-mq Pharmaceuticals Limited. His work at this company focuses on the research and development of pharmaceutical compounds that have the potential to treat various medical conditions. Feng's expertise in the field has led to the successful patenting of multiple innovative compounds.

Collaborations

Feng collaborates with talented individuals in his field, including Qiang Zhang and Shannan Yu. These collaborations enhance the research and development efforts at Beijing Scitech-mq Pharmaceuticals Limited, contributing to the advancement of pharmaceutical innovations.

Conclusion

Shouye Feng is a notable inventor whose work in pharmaceutical compounds is making a significant impact in the industry. His innovative patents and collaborations are essential for the development of new drugs that can address critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…